Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer
A phase 2 trial of High-dose intravenous vitamin C in Rectal cancer, run by Zhou Fuxiang, with a status the registry has not verified recently.
Overview
Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer is a phase 2 interventional study registered as NCT04801511 by Zhou Fuxiang, with 60 participants planned, started 2021-03-08 and due to reach its primary completion in 2023-06-30. Interventions recorded: Vitamin C. Conditions recorded: Rectal Cancer.
Linked to the technology High-dose intravenous vitamin C because the registry's title names it ("high dose intravenous vitamin c") and Rectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialNCT + PD1 + Ketogenic Diet and/or Vitamin C for LARC
Shares High-dose intravenous vitamin C, Rectal cancer and the tag pipeline.
- TrialPilot Trial of Intravenous Vitamin C in Refractory Non-Hodgkin Lymphoma (NHL)
Shares High-dose intravenous vitamin C and the tag pipeline.
- TrialOrgan Preservation in Rectal Cancer by Dose Escalated MR Guided Adaptive Radiotherapy
Shares Rectal cancer and the tag pipeline.
- TrialTo Evaluate Dose and Safety of NanoEcho Particle-1 Using NanoEcho Imaging Device Examinations of Rectal Lymph Nodes in Healthy Volunteers and Rectal Cancer Patients.
Shares Rectal cancer and the tag pipeline.
- TrialAdaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialStudy of MRTX1133 in Patients With Advanced Solid Tumors Harboring a KRAS G12D Mutation
Shares Rectal cancer and the tag pipeline.
- TrialMR-guided Adaptive Radiotherapy Combined With PD-1 Antibody and CAPOX for Locally Advanced Rectal Cancer
Shares Rectal cancer and the tag pipeline.
- TrialA Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With Advanced Cancer of the Colon or Rectum
Shares Rectal cancer and the tag pipeline.